ACTRN12621000661875招募中4 期
Antibody response to COVID-19 vaccination in immunosuppressed patients with autoimmune disease
Dr Ai Tran0 个研究点目标入组 100 人开始时间: 2021年6月1日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •18 years or older
- •Have an autoimmune rheumatic disease or inflammatory bowel disease
- •Treated and stable on immunosuppressive therapy
- •- Patients who do not have an autoimmune disorder and are not on immunosuppressive therapy will be included as a healthy volunteer cohort
排除标准
- •Prior vaccination to COVID-19
- •Previous history of COVID-19 infection
- •Recent prednisolone use within 4 weeks of COVID-19 vaccination
- •Inability to have the COVID-19 vaccine
- •Previous life threatening or end organ disease
研究者
相似试验
招募中
不适用
EVEREST: Evaluation of COVID-19 Vaccination Efficacy and Rare Events in Solid TumoursACTRN12621001307897The Canberra Hospital200
进行中（未招募）
1 期
Immune response to COVID-19 Vaccination in people with Diabetes MellitusType 1 Diabetes MellitusType 2 Diabetes MellitusEUCTR2021-001459-15-ATMedical University of Graz161
尚未招募
不适用
COVID-19 vaccination of vulnerable populations (COVULPOP)COVID-19 vaccine responseCOVID-19Inflammatory and Immune System - Normal development and function of the immune systemRespiratory - Other respiratory disorders / diseasesInfection - Other infectious diseasesACTRN12621001492842Prof Katie Flanagan40
进行中（未招募）
1 期
Response to Covid-19 vaccination in patients with cancerImmune response to Covid-19 vaccination of patients with immune modulatory treatment for cancerEUCTR2021-000905-26-SEDepartment of Oncology, Uppsala University Hospita150
已完成
不适用
Humoral immune response after COVID-19 vaccination.U07.1COVID-19, virus identifiedDRKS00025567Performa NordZentrum für Gesunde ArbeitArbeitsmedizinischer Dienst103